CYduct Diagnostics, Inc. (CYDX)
OTCMKTS · Delayed Price · Currency is USD
0.6201
0.00 (0.00%)
At close: Feb 6, 2026

CYduct Diagnostics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2011FY 2010FY 2009FY 2008FY 2007
Period Ending
Mar '12 Dec '11 Dec '10 Dec '09 Dec '08 Dec '07
Net Income
0.14-0.5-1.19-2.31-0.53-0.46
Depreciation & Amortization
0.010.010.030.030.030.02
Loss (Gain) From Sale of Assets
---0.02--
Asset Writedown & Restructuring Costs
---1.54--
Stock-Based Compensation
0.320.360.540.20.32-
Other Operating Activities
-0.08-0.080.16-0.05--
Change in Accounts Receivable
0.010.03-00-0.02-0.02
Change in Inventory
0.070.07-0.120.130.08-0
Change in Accounts Payable
-0.090.010.05-0.070.070.01
Change in Other Net Operating Assets
-0.530.040.29-0.01--
Operating Cash Flow
-0.16-0.05-0.24-0.51-0.05-0.45
Capital Expenditures
---0.03---
Investing Cash Flow
---0.03---
Long-Term Debt Issued
--0.0100.040.01
Long-Term Debt Repaid
--0.02----
Net Debt Issued (Repaid)
-0.03-0.020.0100.040.01
Issuance of Common Stock
0.190.070.180.580.020.43
Other Financing Activities
------0.01
Financing Cash Flow
0.160.050.180.580.060.43
Net Cash Flow
0-0-0.080.080.01-0.02
Free Cash Flow
-0.16-0.05-0.26-0.51-0.05-0.45
Free Cash Flow Margin
-46.63%-16.31%-61.30%-120.83%-11.47%-135.55%
Cash Interest Paid
--0.01--0.01
Levered Free Cash Flow
-0.54-0.070.15-0.230.15-
Unlevered Free Cash Flow
-0.54-0.060.17-0.20.17-
Change in Working Capital
-0.540.160.220.070.13-0.01
Source: S&P Global Market Intelligence. Standard template. Financial Sources.